The results of this study showed that IL-6 increased significantly at 2 days after CSM-TACE and began to decrease at 5 days after CSM-TACE, which was consistent with the peak of IL-6 at 3days after TACE for liver cancer reported by Jekarl et al. The gene discussed is IL6; the disease is liver cancer.